Latest webfg news

Oxford Biomedica delivers solid H1 growth, record commercial wins 08:49
Astrazeneca secures two positive regulatory opinions in Europe 21 Sep
Director dealings: Astrazeneca CEO raises stake 18 Sep
Deutsche Bank upgrades Astrazeneca to 'hold' 15 Sep
Berenberg upgrades GSK to 'buy', raises target price 15 Sep
GSK acquires global rights to multiple myeloma asset from Chimagen Biosciences 15 Sep
Astrazeneca's Etcamah trial fails to meet primary endpoint 14 Sep
GSK highlights pipeline momentum with Ris‑Rez phase III success, Jideytro first‑line efficacy 14 Sep
Genus announces £60m buyback as FY profits rise but shares drop on revenue miss 10 Sep
GSK gets Japanese approval for new ready‑to‑use shingles vaccine format 10 Sep
AstraZeneca sees positive results from lung cancer drug trial 08 Sep
AstraZeneca's breast cancer drug granted accelerated approval in the US 07 Sep
GSK advances mRNA flu shot after Phase II success 01 Sep
AstraZeneca lifts lung‑cancer pipeline with Zegfrovy deal, Tagrisso data 01 Sep
Astrazeneca's Tezspire delivers positive results in EoE trial 27 Aug
SkinBioTherapeutics names Anita Slater as interim CFO 24 Aug
GSK notches major regulatory milestones in Japan and US 24 Aug
Oxford Nanopore announces new 2030 targets as interim losses narrow 19 Aug
Deutsche Bank downgrades Oxford Biomedica after 'disappointing' H1 results 18 Aug
AstraZeneca posts mixed lung‑cancer trial updates 17 Aug
  • «
  • 2026-05
  • 2026-06
  • 2026-07
  • 2026-08
  • 2026-09
Advertising

SMART BOX info

More about you
  • High
  • Medium
  • Low

You are seeing these quotes based on previous browsing related to sectors such as:

  • {{ item.Description }}

You are seeing these stories as you have shown an interest in the following categories

  • {{ item.Description }}
Advertising